Corporate Presentation to Highlight Company's Gene Therapies for Cancer and Diabetes AUSTIN, Texas, Sept. 8, 2022 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a...

Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company...

Paramount Global (NASDAQ: PARA; PARAA) today announced that Bob Bakish, President and Chief Executive Officer of Paramount Global, will participate in a question and answer session during the...

Spotlight on the ESG & Sustainability Performance Management expert solution Over 40 customer speakers share best practices using real-world use cases Walking the talk with sustainable practices...

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company) a leader in the development of targeted radiotherapies for patients with unmet needs, today announced that it will be...

Leading companies share digital strategies and best practices for accelerating time to market PLEASANTON, Calif., Sept. 8, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced its 2022...

Kintara Therapeutics, Inc.(Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that three...

Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, today announced that Dr. Samarendra Mohanty, Co-Founder and...

Company to Present Corporate Update During Investor Conference, Sept. 14, 2022, at 9:00am ET RADNOR, Pa., Sept. 8, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage...

Findings from nine studies across a breadth of tumor types and genomic alterations demonstrate the clinical benefits delivered by Caris' whole exome, whole transcriptome approach to molecular...